MAPK4 promotes triple negative breast cancer growth and reduces tumor sensitivity to PI3K blockade

Wei Wang(Ministry of Education of the People's Republic of China), Feng Yang(Baylor College of Medicine)
Nature Communications
January 11, 2022
10.1038/s41467-021-27921-1
Cited by 46

Related Papers

MAPK4 overexpression promotes tumor progression via noncanonical activation of AKT/mTOR signaling
|Journal of Clinical Investigation|2019|104
MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT
|Journal of Clinical Investigation|2021|62
Stromal TGF-β signaling induces AR activation in prostate cancer
|Oncotarget|2014|48
Cooperative activation of PDK1 and AKT by MAPK4 enhances cancer growth and resistance to therapy
|PLoS Biology|2023|13
The association of FGF-21 with the risk of newly diagnosed type-2 diabetes mellitus: a cross-sectional study in Southern China
|BMC Endocrine Disorders|2023|3